Is BXPHF or MO a better dividend investment in 2026?

BXPHF currently yields 5000.00% with a 5% 5-year dividend growth rate. MO yields 6.27% with 4.3% growth. The better choice depends on your goal: BXPHF offers higher current income.

What is the dividend yield difference between BXPHF and MO?

BXPHF has a forward dividend yield of 5000.00% ($2.00/share annually). MO yields 6.27% ($4.20/share annually). The yield gap is 4993.73 percentage points.

Home › Compare › BXPHF vs MO

BXPHF vs MO: Dividend Comparison 2026

BXPHF yields 5000.00% · MO yields 6.27%● Live data

vsPost on X →

After 10 years · $10,000 invested · DRIP enabled

🏆 BXPHF wins by $62217131802825.28M in total portfolio value

INVESTMENT

TIME HORIZON10 years

BXPHF

● Live price

5000.00%

Share price

$0.04

Annual div

$2.00

5Y div CAGR

Payout ratio

50%

After 10 yrs · $10,000 · DRIP

Portfolio value

$62217131802825.35M

Annual income

$59,861,980,287,378,210,000.00

Full BXPHF calculator →

Altria Group Inc.

● Live price

6.27%

Share price

$67.02

Annual div

$4.20

5Y div CAGR

22.6%

Payout ratio

50%

After 10 yrs · $10,000 · DRIP

Portfolio value

$77.7K

Annual income

$28,968.54

Full MO calculator →

Portfolio growth — BXPHF vs MO

📍 BXPHF pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis Period	BXPHF	MO
2008–2009 GFC	— No data	— No data
2020 Q1–Q2 COVID	— No data	— No data
2022 Q4 Rate Hike	— No data	— No data

Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.

📅

Dividend Calendar Overlap

Combined, BXPHF + MO cover 0 of 12 months — good coverage

Jan

—

Feb

—

Mar

—

Apr

—

May

—

Jun

—

Jul

—

Aug

—

Sep

—

Oct

—

Nov

—

Dec

—

BXPHF pays

MO pays

Both pay

Neither

💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

BXPHF

Annual income on $10K today (after 15% tax)

$425,000.00/yr

After 10yr DRIP, annual income (after tax)

$50,882,683,244,271,480,000.00/yr

Annual income on $10K today (after 15% tax)

$532.68/yr

After 10yr DRIP, annual income (after tax)

$24,623.26/yr

At 15% tax rate, BXPHF beats the other by $50,882,683,244,271,450,000.00/year in after-tax income after 10 years on $10,000

⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of BXPHF + MO for your $10,000?

BXPHF: 50%MO: 50%

100% MO50/50100% BXPHF

Portfolio after 10yr

$31108565901412.71M

Annual income

$29,930,990,143,689,120,000.00/yr

Blended yield

96.21%

📊

Analyst Conviction Gap

Where Wall Street is most bullish on MO right now

BXPHF

No analyst data

Price Target

$0.27

+575.0% upside vs current

Range: $0.27 — $0.27

Altman Z

-4.7

Piotroski

3/9

Analyst Ratings

Buy

Hold

Sell

Consensus: Buy

Price Target

$61.25

-8.6% upside vs current

Range: $47.00 — $68.00

Altman Z

3.2

Piotroski

7/9

Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.

🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

BXPHF buys

MO buys

Politician	Chamber	Ticker	Type	Amount	Date
Ro Khanna	🏢 House	$MO	▲ Buy	$1,000 - $15,000	2025-08-04
Sheri Biggs	🏢 House	$MO	▼ Sell	$1,001 - $15,000	2025-03-19
Pete Sessions	🏢 House	$MO	▼ Sell	$1,001 - $15,000	2024-09-10
Ro Khanna	🏢 House	$MO	▲ Buy	$1,001 - $15,000	2024-03-20
Ro Khanna	🏢 House	$MO	▲ Buy	$1,001 - $15,000	2024-02-13
Virginia Foxx	🏢 House	$MO	▼ Sell	$1,001 - $15,000	2024-01-16
Virginia Foxx	🏢 House	$MO	▲ Buy	$1,001 - $15,000	2024-01-11
Ro Khanna	🏢 House	$MO	▼ Sell	$1,001 - $15,000	2024-01-10
Ro Khanna	🏢 House	$MO	▲ Buy	$1,001 - $15,000	2024-01-10
Virginia Foxx	🏢 House	$MO	▼ Sell	$15,001 - $50,000	2024-01-10

STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →

MetricBXPHFMO

Forward yield	5000.00% ✓	6.27%
Annual dividend / share	$2.00	$4.20 ✓
Payout ratio	50%	50%
1-year div growth	0%	0%
5-year div CAGR	0%	22.6% ✓
Portfolio after 10y	$62217131802825.35M ✓	$77.7K
Annual income after 10y	$59,861,980,287,378,210,000.00 ✓	$28,968.54
Total dividends collected	$62057786341622.61M ✓	$72.0K
Payment frequency	quarterly	quarterly
Sector	Stock	Consumer Staples
Analyst price target	$0.27	$61.25 ✓

Year-by-year: BXPHF vs MO ($10,000, DRIP)

Year	BXPHF Portfolio	BXPHF Income/yr	MO Portfolio	MO Income/yr	Gap
1← crossover	$510,700	$500,000.00	$10,558	$768.31	+$500.1K → BXPHF
2	$24,410,935	$23,864,485.98	$11,352	$1,015.87	+$24.40M → BXPHF
3	$1,092,192,501	$1,066,072,800.30	$12,482	$1,367.86	+$1092.18M → BXPHF
4	$45,746,366,951	$44,577,720,975.17	$14,103	$1,883.39	+$45746.35M → BXPHF
5	$1,793,932,828,410	$1,744,984,215,772.56	$16,472	$2,664.91	+$1793932.81M → BXPHF
6	$65,871,973,805,320	$63,952,465,678,921.49	$20,024	$3,897.79	+$65871973.79M → BXPHF
7	$2,265,146,887,602,700	$2,194,663,875,631,007.20	$25,537	$5,933.74	+$2265146887.58M → BXPHF
8	$72,954,689,148,998,180	$70,530,981,979,263,280.00	$34,478	$9,476.77	+$72954689148.96M → BXPHF
9	$2,201,076,182,660,884,700	$2,123,014,665,271,456,500.00	$49,776	$16,022.63	+$2201076182660.83M → BXPHF
10	$62,217,131,802,825,350,000	$59,861,980,287,378,210,000.00	$77,699	$28,968.54	+$62217131802825.28M → BXPHF

BXPHF vs MO: Complete Analysis 2026

BXPHF — Stock

Botanix Pharmaceuticals Limited engages in the research and development of dermatology and antimicrobial products in Australia. The company engages in development of novel treatments for common skin diseases and infections. Its product pipeline includes Sofpironium Bromide, a drug in development for the treatment of primary axillary hyperhidrosis that has completed Phase 3 clinical programs; BTX 1503, a transdermal gel formulation for the treatment of serious acne in adults and teenagers that has completed Phase II clinical trials; BTX 1801, which has completed Phase IIb clinical trials for the treatment of staphylococcus aureus and methicillin resistant staphylococcus aureus; BTX 1702 that is in Phase IIb clinical trials for the treatment of papulopustular rosacea; and BTX 1204A for the treatment of atopic dermatitis. The company was incorporated in 1984 and is based in Leederville, Australia.

Full BXPHF Calculator →

MO — Consumer Staples

Altria Group, Inc., through its subsidiaries, manufactures and sells smokeable and oral tobacco products in the United States. The company provides cigarettes primarily under the Marlboro brand; cigars and pipe tobacco principally under the Black & Mild brand; and moist smokeless tobacco products under the Copenhagen, Skoal, Red Seal, and Husky brands, as well as provides on! oral nicotine pouches. It sells its tobacco products primarily to wholesalers, including distributors; and large retail organizations, such as chain stores. Altria Group, Inc. was founded in 1822 and is headquartered in Richmond, Virginia.

Full MO Calculator →

📬

Get this BXPHF vs MO comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

BXPHF vs SCHD BXPHF vs JEPI BXPHF vs O BXPHF vs KO BXPHF vs MAIN BXPHF vs PM BXPHF vs BTI BXPHF vs PG

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.